Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis

Journal of the American Society of Nephrology

Volumn 11, Issue 8, 2000, Pages 1426-1438

  Aten, Jan ^a,b   Roos, Anja ^a   Claessen, Nike ^a   Schilder Tol, Esther J M ^a   Ten Berge, Ineke J M ^a   Weening, Jan J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD134 ANTIGEN; CD134 LIGAND; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MOLECULAR INTERACTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION;

EID: 0033929388     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v1181426     Document Type: Article

References (54)

1. Gruss HJ, Dower SK: Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 85: 3378-3404, 1995
2. Nagata S: Apoptosis by death factor. Cell 88: 355-365, 1997
3. Moss ML, Jin SLC, Milla ME, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Warner J, Willard D, Becherer JD: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385: 733-736, 1997
4. Papoff G, Cascino I, Eramo A, Starace G, Lynch DH, Ruberti G: An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J Immunol 156: 4622-4630, 1996
5. Stout RD, Suttles J: The many roles of CD40 in cell-mediated inflammatory responses. Immunol Today 17: 487-492, 1996
6. Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A: Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 158: 977-983, 1997
7. Wu J, Zhou T, Zhang J, He J, Gause WC, Mountz JD: Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc Natl Acad Sci USA 91: 2344-2348, 1994
8. Jodo S, Kobayashi S, Kayagaki N, Ogura N, Feng Y, Amasaki Y, Fujisaku A, Azuma M, Yagita H, Okumura K, Koike T: Serum levels of soluble Fas/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases. Clin Exp Immunol 107: 89-95, 1997
9. + T cells in systemic lupus erythematosus (SLE) and the relation with activation-induced apoptosis. Clin Exp Immunol 106: 218-229, 1996
10. Heilig B, Fiehn C, Brockhaus M, Gallati H, Pezzutto A, Hunstein W: Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol 13: 321-328, 1993
11. Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T, Yazici H, Guerne PA: Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 24: 303-308, 1997
12. Font J, Pallares L, Martorell J, Martinez E, Gaya A, Vives J, Ingelmo M: Elevated soluble CD27 levels in serum of patients with systemic lupus erythematosus. Clin Immunol Immunopathol 81: 239-243, 1996
13. Caligaris-Cappio F, Bertero MT, Converso M, Stacchini A, Vinante F, Romagnani S, Pizzolo G: Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity. Clin Exp Immunol 13: 339-343, 1995
14. Desai-Mehta A, Lu L, Ramsey-Goldman R, Datta SK: Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97: 2063-2073, 1996
15. Koshy M, Berger D, Crow MK: Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 98: 826-837, 1996
16. Early GS, Zhao W, Burns CM: Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand Black X New Zealand White mice: Response correlates with the absence of an anti-antibody response. J Immunol 157: 3159-3164, 1996
17. Berden JHM: Lupus nephritis. Kidney Int 52: 538-558, 1997
18. Kashgarian M: Lupus nephritis: Lessons from the path lab. Kidney Int 45: 928-938, 1994
19. Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C: "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 50: 2047-2053, 1996
20. Churg J, Bernstein J, Glassock RJ: Lupus nephritis. In: Renal Diseases, Classification and Atlas of Glomerular Diseases, edited by Churg J, Bernstein J, Glassock RJ, New York, Igaku-Shoin, 1995, p 151
21. Yellin MJ, D'Agati V, Parkinson G, Soh-Yung Han A, Szema A, Baum D, Estes D, Szabolcs M, Chess L: Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum 40: 124-134, 1997
22. Neale TJ, Rüger BM, Macaulay H, Dunbar PR, Hasan Q, Bourke A, Murray-McIntosh RP, Kitching AR: Tumor necrosis factor-α is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol 146: 1444-1454, 1995
23. 2-induced systemic autoimmunity. Scand J Immunol 43: 507-518, 1996
24. Roos A, Schilder-Tol EJ, Weening JJ, Aten J: Strong expression of CD 134 (OX40), a member of the TNF receptor family, in a T helper 2-type cytokine environment. J Leukocyte Biol 64: 503-510, 1998
25. Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, Delespesse G: Expression and function of OX40 ligand on human dendritic cells. J Immunol 159: 3838-3848, 1997
26. Baum PR, Gayle RB III, Ramsdell F, Srinivasan S, Sorensen RA, Watson ML, Seldin MF, Clifford KN, Grabstein K, Alderson MR, Goodwin RG, Fanslow WC: Identification of OX40 ligand and preliminary characterization of its activities on OX40 receptor. Circ Shock 44: 30-34, 1994
27. + T cells with homology to tumour necrosis factor. J Exp Med 180: 757-762, 1994
28. Flynn S, Toellner KM, Raykundalia C, Goodall M, Lane P: CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J Exp Med 188: 297-304, 1998
29. Ohshima Y, Yang LP, Uchiyama T, Tanaka Y, Baum P, Sergerie M, Hermann P, Delespesse G: OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood 92: 3338-3345, 1998
30. Gramaglia I, Weinberg AD, Lemon M, Croft M: OX-40 ligand: A potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol 161: 6510-6517, 1998
31. Stüber E, Neurath M, Calderhead D, Fell HP, Strober W: Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 5: 507-521, 1995
32. Stüber E, Strober W: The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response. J Exp Med 183: 979-989, 1996
33. Imura A, Hori T, Imada K, Ishikawa T, Tanaka Y, Maeda M, Imamura S, Uchiyama T: The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 183: 2185-2195, 1996
34. Imura A, Hori T, Imada K, Kawamata S, Tanaka Y, Imamura S, Uchiyama T: OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: Implication for the possible involvement of OX40 in leukemic cell infiltration. Blood 89: 2951-2958, 1997
35. Buysmann S, Schellekens PT, Tax WJ, ten Berge IJM: Different CD3/T cell receptor monoclonal antibodies have distinct capacities to induce adhesion of T lymphocytes to endothelium. J Lab Clin Med 130: 91-101, 1997
36. Latza U, Dürkop H, Schnittger S, Ringeling J, Eitelbach F, Hummel M, Fonatsch C, Stein H: The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur J Immunol 24: 677-683, 1994
37. Austin HA III, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, Decker JL, Balow JE: Prognostic factors in lupus nephritis: Contribution of renal histologic data. Am J Med 75: 382-391, 1983
38. Dunn OJ: Multiple comparisons among means. J Am Stat Assoc 56: 52-64, 1961
39. Via SV, Shearer GM: T-cell interactions in autoimmunity: Insights from a murine model of graft-versus-host disease. Immunol Today 9: 207-213, 1988
40. Termaat RM, Assmann KJM, Van Son JPHF, Dijkman HBPM, Koene RAP, Berden JHM: Antigen-specificity of antibodies bound to glomeruli of mice with systemic lupus erythematosus-like syndromes. Lab Invest 68: 164-173, 1993
41. Assmann KJM, Van Son JPHF, Dijkman HBPM, Koene RAP: A nephritogenic rat monoclonal antibody to mouse aminopeptidase A: Induction of massive albuminuria after a single intravenous injection. J Exp Med 175: 623-635, 1992
42. Chalupny NJ, Peach R, Hollenbaugh D, Ledbetter JA, Farr AG, Aruffo A: T-cell activation molecule 4-1BB binds to extracellular matrix proteins. Proc Natl Acad Sci USA 89: 10360-10364, 1992
43. Loo DT, Chalupny NJ, Bajorath J, Shuford WW, Mittler RS, Aruffo A: Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB. J Biol Chem 272: 6448-6456, 1997
44. Gattorno M, Picco P, Barbano G, Stalla F, Sormani MP, Buoncompagni A, Gusmano R, Borrone C, Pistoia V: Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: Pathogenetic implications. J Rheumatol 25: 361-365, 1998
45. Grell M, Wajant H, Zimmermann G, Scheurich P: The type 1 receptor (CD 120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci USA 95: 570-575, 1998
46. Vandenabeele P, Declercq W: Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol 5: 392-399 1995
47. Lucas R, Garcia I, Donati YR, Hribar M, Mandriota SJ, Giroud C, Buurman WA, Fransen L, Suter PM, Nunez G, Pepper MS, Grau GE: Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells. Eur J Immunol 28: 3577-3586, 1998
48. Declercq W, Denecker G, Fiers W, Vandenabeele P: Cooperation of both TNF receptors in inducing apoptosis: Involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J Immunol 161: 390-399, 1998
49. Weiss T, Grell M, Siemienski K, Muhlenbeck F, Durkop H, Pfizenmaier K, Scheurich P, Wajant H: TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J Immunol 161: 3136-3142, 1998
50. Grell M, Douni E, Wajant H, Löhden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802, 1995
51. Lucas R, Juillard P, Decoster E, Redard M, Burger D, Donati Y, Giroud C, Monso-Hinard C, De Kesel T, Buurman WA, Moore MW, Dayer JM, Fiers W, Bluethmann H, Grau GE: Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol 27: 1719-1725, 1997
52. Grell M, Becke FM, Wajant H, Mannel DN, Scheurich P: TNF receptor type 2 mediates thymocyte proliferation independently of TNF receptor type 1. Eur J Immunol 28: 257-263, 1998
53. Lazdins JK, Grell M, Walker MR, Woods-Cook K, Scheurich P, Pfizenmaier K: Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells. J Exp Med 185: 81-90, 1997
54. Matsumura Y, Hori T, Kawamata S, Imura A, Uchiyama T: Intracellular signaling of gp34, the OX40 ligand: Induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40. J Immunol 163: 3007-3011, 1999